<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Kaival Biochem]]></title><description><![CDATA[Kaival Biochem]]></description><link>https://www.kaivalbiochem.com/blog</link><generator>RSS for Node</generator><lastBuildDate>Thu, 24 Sep 2026 15:12:39 GMT</lastBuildDate><atom:link href="https://www.kaivalbiochem.com/blog-feed.xml" rel="self" type="application/rss+xml"/><item><title><![CDATA[Chiral Resolving Agents in Pharmaceutical Manufacturing Applications]]></title><description><![CDATA[Category 02 — Technical Insights A small change in molecular orientation can change how a pharmaceutical compound behaves. In many drug substances and intermediates, two molecules may share the same atoms and bonds, yet differ in three-dimensional arrangement. One form can support the intended activity, while the other may show lower activity, unwanted effects, or a different impurity profile. This is why chirality sits at the centre of many pharmaceutical manufacturing routes. For...]]></description><link>https://www.kaivalbiochem.com/post/chiral-resolving-agents-in-pharmaceutical-manufacturing-applications</link><guid isPermaLink="false">6a8fff6b190fae3a61b889e0</guid><pubDate>Thu, 27 Aug 2026 09:12:15 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/74a337_f596c19d0de34b5d8d395edfc24f0671~mv2.png/v1/fit/w_1000,h_768,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Harsh Upadhyay</dc:creator></item></channel></rss>